Skip to main navigation
Back Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Careers
    • Contact Us
  • Product Candidates
    • Pipeline
    • Rivo-cel
    • BPX-601
    • BPX-701
  • Technology
    • Overview
    • CaspaCIDe
    • GoCAR-T
    • Scientific Literature
    • Abstracts & Presentations
  • Clinical Trials
    • Rivo-cel in Blood Cancers &
      Inherited Blood Disorders
    • BPX-601 (GoCAR-T) and
      BPX-701 (TCR)
  • Investors & Media

    Investor Relations

    • Investor Center Home
    • News & Events
      • Press Releases
      • Events and Presentations
      • Corporate Presentation
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Historical Price Lookup
      • Analyst Coverage
      • Investment Calculator
    • Financial Information
      • Annual Reports and Proxies
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Shareholder Services
      • Investor FAQ
      • Contact Investor Relations
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Careers
    • Contact Us
  • Product Candidates
    • Pipeline
    • Rivo-cel
    • BPX-601
    • BPX-701
    • CD19 Program
  • Technology
    • Overview
    • CaspaCIDe
    • GoCAR-T
    • Scientific Literature
    • Abstracts & Presentations
  • Clinical Trials
    • Rivo-cel in Blood Cancers &
      Inherited Blood Disorders
    • BPX-601 (GoCAR-T) and
      BPX-701 (TCR)
  • Investors & Media

    Investor Relations

    • Investor Center Home
    • News & Events
      • Press Releases
      • Events and Presentations
      • Corporate Presentation
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Historical Price Lookup
      • Analyst Coverage
      • Investment Calculator
    • Financial Information
      • Annual Reports and Proxies
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Shareholder Services
      • Investor FAQ
      • Contact Investor Relations
Bellicum Pharmaceuticals, Inc. - Investors and Media

Investor Relations

  • Investor Center Home
  • News & Events
    • Press Releases
    • Events and Presentations
    • Corporate Presentation
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Price Lookup
    • Analyst Coverage
    • Investment Calculator
  • Financial Information
    • Annual Reports and Proxies
    • SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Shareholder Services
    • Investor FAQ
    • Contact Investor Relations

Tools

  • Email Alerts
  • RSS Feeds
  • Print Page

Investor Center


SEC Filing Details

Document Details

Form
CT ORDER
Filing Date
Jul 26, 2018
Document Date
Jul 26, 2018
Form Description
CT ORDER
Filing Group
Other
Company
Bellicum Pharmaceuticals Inc
Issuer
BELLICUM PHARMACEUTICALS, INC

Filing Formats

View HTML
Download PDF
Download DOC

About Us

  • Overview
  • Management Team
  • Board of Directors
  • Careers
  • Contact Us

Product Candidates

  • Pipeline
  • Rivo-cel
  • BPX-601
  • BPX-701

Technology

  • Overview
  • CaspaCIDe
  • GoCAR-T
  • Scientific Literature
  • Abstracts & Presentations

Clinical Trials

  • Rivo-cel in Blood Cancers &
    Inherited Blood Disorders
  • BPX-601 (GoCAR-T) and
    BPX-701 (TCR)

Investors & Media

IR Footer

  • Investor Center Home
  • News & Events
  • Stock Information
  • Financial Information
  • Corporate Governance
  • Shareholder Services

Copyright © 2019 Bellicum Pharmaceuticals Inc. All Rights Reserved

  • Contact Us
  • Privacy Policy
  • Terms of Use